Veeva Systems Inc. (NYSE:VEEV – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the twenty-four analysts that are presently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, eight have given a hold recommendation and fifteen have given a buy recommendation to the company. The average twelve-month target price among analysts that have issued a report on the stock in the last year is $236.92.
Several equities analysts recently issued reports on VEEV shares. Guggenheim increased their target price on Veeva Systems from $233.00 to $249.00 and gave the stock a “buy” rating in a research note on Tuesday, October 1st. Barclays raised their price target on shares of Veeva Systems from $240.00 to $260.00 and gave the company an “overweight” rating in a research note on Friday, November 8th. Truist Financial upped their price objective on Veeva Systems from $197.00 to $207.00 and gave the stock a “hold” rating in a research note on Tuesday, September 3rd. UBS Group lifted their price target on Veeva Systems from $185.00 to $215.00 and gave the stock a “neutral” rating in a research note on Monday, August 26th. Finally, StockNews.com raised Veeva Systems from a “hold” rating to a “buy” rating in a research report on Saturday, November 9th.
Insider Transactions at Veeva Systems
Hedge Funds Weigh In On Veeva Systems
Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Peapack Gladstone Financial Corp increased its position in Veeva Systems by 5.6% during the 3rd quarter. Peapack Gladstone Financial Corp now owns 70,147 shares of the technology company’s stock worth $14,721,000 after purchasing an additional 3,741 shares during the period. Tidal Investments LLC increased its position in Veeva Systems by 77.1% during the 3rd quarter. Tidal Investments LLC now owns 22,330 shares of the technology company’s stock worth $4,686,000 after purchasing an additional 9,724 shares during the period. Wilmington Savings Fund Society FSB acquired a new position in Veeva Systems during the 3rd quarter worth approximately $168,000. World Investment Advisors LLC acquired a new position in Veeva Systems during the 3rd quarter worth approximately $2,131,000. Finally, Sanctuary Advisors LLC increased its position in Veeva Systems by 19.7% during the 3rd quarter. Sanctuary Advisors LLC now owns 7,335 shares of the technology company’s stock worth $1,589,000 after purchasing an additional 1,206 shares during the period. Institutional investors and hedge funds own 88.20% of the company’s stock.
Veeva Systems Price Performance
Veeva Systems stock opened at $226.88 on Friday. The stock has a market capitalization of $36.74 billion, a PE ratio of 60.50, a price-to-earnings-growth ratio of 2.09 and a beta of 0.81. Veeva Systems has a 12 month low of $165.12 and a 12 month high of $240.68. The business has a 50 day simple moving average of $214.98 and a 200-day simple moving average of $201.48.
Veeva Systems (NYSE:VEEV – Get Free Report) last released its quarterly earnings data on Wednesday, August 28th. The technology company reported $1.07 earnings per share for the quarter, topping analysts’ consensus estimates of $1.04 by $0.03. The company had revenue of $676.18 million for the quarter, compared to analyst estimates of $667.21 million. Veeva Systems had a return on equity of 13.30% and a net margin of 23.91%. On average, equities research analysts anticipate that Veeva Systems will post 4.21 EPS for the current fiscal year.
About Veeva Systems
Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.
See Also
- Five stocks we like better than Veeva Systems
- How to Evaluate a Stock Before Buying
- Cerence Up 155% in 2 Days: SoundHound AI’s Fierce Competitor
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Why Warren Buffett Is Selling: A Look at His Latest Market Moves
- 3 Healthcare Dividend Stocks to Buy
- Why Amazon Shares May Never Trade Below $200 Again
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.